ArticleBMC urology2026
Effect of vitamin B12 replacement therapy in patients with premature ejaculation with B12 deficiency.
Article in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVitamin B12 plays a key role in the serotonergic pathway; we predicted that B12 replacement could be beneficial in the treatment of premature ejaculation (PE) in patients with B12 deficiency. We aimed to investigate the response to vitamin B12 replacement in PE patients with vitamin B12 deficiency.
methodsBetween January 2025 and June 2025, a total of 152 individuals were included in this study, comprising 92 patients aged 18–45 who were diagnosed with PE and 60 healthy controls. The blood vitamin B12 levels of all participants were examined. Thirty-four patients with PE who presented with vitamin B12 deficiency were re-evaluated for ejaculation time after vitamin B12 replacement.
resultsThe mean blood vitamin B12 level was 237.8 ± 91.4 ng/L in the PE group and 297 ± 141.7 ng/L in the control group (p = 0.002). Following vitamin B12 replacement in the PE group with vitamin B12 deficiency, there was a statistically significant decrease in Premature Ejaculation Diagnostic Tool (PEDT) scores, a significant increase in Premature Ejaculation Profile (PEP) scores, and an increase in intravaginal latency time (p < 0.001). Of the patients diagnosed with PE who received B12 replacement therapy, 25 (73.5%) were satisfied with the treatment, while 9 (26.5%) were dissatisfied. Treatment satisfaction rates were 87.5% in those with lifelong PE and 61.1% in those with acquired PE (p = 0.082).
conclusionIn PE patients with B12 deficiency, normalizing blood B12 levels may be a viable treatment option. This is the first study to assess the effect of B12 replacement in PE patients with vitamin B12 deficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.